CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 201 enrolled
Drug / intervention
Abstinencebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03276221
NCT03276221N/ACompleted

Cognitive Recovery With Cannabis Abstinence Among High School-Aged Adolescents

Massachusetts General Hospital·interventional·Posted Sep 8, 2017·Updated Feb 1, 2024

In Brief

A clinical study evaluating Abstinence for Cannabis Use and 2 related conditions. Completed, enrolled 201 participants across 1 site.

Detailed Summary

This study will use a randomized controlled design to test whether 30 days of cannabis abstinence, compared to 30 days of monitoring, is associated with improvements in cognitive functioning. Non-using controls will also be enrolled to determine the clinical significance of any cognitive improvements with abstinence.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedSep 8, 2017
Enrollment StartAug 7, 2017
Primary CompletionNov 9, 2022
TodayJul 2, 2026
Enrollment to primary: 5.3 yearsPosted 8.8 years ago

Interventions

Abstinencebehavioral

Cannabis users randomized to this condition will be enrolled in a contingency management intervention for 30 days of cannabis abstinence.